Recent Advancement in mRNA Vaccine Development and Applications
Messenger RNA (mRNA) vaccine development for preventive and therapeutic applications has evolved rapidly over the last decade. The mRVNA vaccine has proven therapeutic efficacy in various applications, including infectious disease, immunotherapy, genetic disorders, regenerative medicine, and cancer....
Main Authors: | Nojoud Al Fayez, Majed S. Nassar, Abdullah A. Alshehri, Meshal K. Alnefaie, Fahad A. Almughem, Bayan Y. Alshehri, Abdullah O. Alawad, Essam A. Tawfik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/7/1972 |
Similar Items
-
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
by: Liusheng Wu, et al.
Published: (2024-02-01) -
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
by: Michele Schlich, et al.
Published: (2021-05-01) -
Lipid-mRNA nanoparticles landscape for cancer therapy
by: Yin Li, et al.
Published: (2022-10-01) -
An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
by: Md. Motiar Rahman, et al.
Published: (2021-03-01) -
A Comprehensive Review of mRNA Vaccines
by: Vrinda Gote, et al.
Published: (2023-01-01)